289 studies found for:    Osteosarcoma
Show Display Options
Rank Status Study
21 Recruiting Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Condition: Pulmonary Relapse of Osteosarcoma
Intervention: Drug: Inhaled Lipid Cisplatin (ILC)
22 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
23 Unknown  Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Condition: Osteosarcoma
Interventions: Dietary Supplement: Curcumin powder;   Dietary Supplement: Ashwagandha extract
24 Completed Sorafenib in Relapsed High Grade Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: sorafenib
25 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
26 Recruiting Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma;   Adult Angiosarcoma;   Adult Desmoplastic Small Round Cell Tumor;   Adult Epithelioid Hemangioendothelioma;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Extraskeletal Osteosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma;   Adult Malignant Mesenchymoma;   Adult Neurofibrosarcoma;   Adult Rhabdomyosarcoma;   Adult Synovial Sarcoma;   Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Conjunctival Kaposi Sarcoma;   Dermatofibrosarcoma Protuberans;   Gastrointestinal Stromal Tumor;   Metastatic Adult Malignant Fibrous Histiocytoma of Bone;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Malignant Fibrous Histiocytoma of Bone;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Kaposi Sarcoma;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Small Intestine Leiomyosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: vismodegib;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis;   Other: pharmacological study
27 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy for positive p-glycoprotein expression;   Other: Chemotherapy for negative p-glycoprotein expression
28 Active, not recruiting Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
Conditions: Metastatic Osteosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Osteosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: cixutumumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
29 Completed Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
Condition: Osteosarcoma
Intervention: Drug: SLIT Cisplatin
30 Recruiting Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
Condition: Osteosarcoma
Intervention:
31 Recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo
32 Active, not recruiting Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Conditions: Bone Cancer;   Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: therapeutic angiotensin-(1-7);   Other: laboratory biomarker analysis
33 Active, not recruiting Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Other: laboratory biomarker analysis
34 Recruiting Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide
35 Not yet recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Lithium Carbonate
36 Active, not recruiting A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Conditions: Osteosarcoma;   Malignant Fibrous Histiocytoma (MFH) of Bone
Interventions: Biological: Bevacizumab;   Drug: Chemotherapy (Cisplatin, Doxorubicin, Methotrexate, Ifosfamide, Etoposide)
37 Recruiting Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Thiotepa
38 Completed A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
Conditions: Neoplasm Metastasis;   Osteosarcoma
Interventions: Drug: OncoLAR® (Registered Trademark);   Drug: tamoxifen
39 Recruiting Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
Conditions: Ewing Sarcoma;   Osteosarcoma
Intervention: Other: MRI
40 Completed
Has Results
Chemotherapy for Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Pemetrexed

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years